Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion type Assertion NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_head.
- NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_provenance.
- NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion evidence source_evidence_literature NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_provenance.
- NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion SIO_000772 15948173 NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_provenance.
- NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion wasDerivedFrom befree-20140225 NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_provenance.
- NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion wasGeneratedBy ECO_0000203 NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_provenance.